Ketaneserinol as an agent to reduce intraocular pressure
US5290781A · kind A · utility
27Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 1993 |
| Grant date | Mar 1, 1994 |
| Priority date | — |
| Expiry date | Jan 5, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of ketanserinol as an ophthalmic therapeutic agent to reduce intraocular pressure and its method of use for treating glaucoma by systemic administration of ketanserinol, it salts, esters or prodrugs to a patient or more particularly, topically administering ketanserinol and salts thereof to the eye of a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.